miCure Therapeutics is a leading-edge biotech company established in September 2013 in the Science Park of Ness Ziona, Israel. The company is focused on micro-RNA therapeutics and diagnostics for the central nervous system. miCure obtained an exclusive worldwide license from Yeda Research & Development Company Ltd. to develop products based on technologies emanating from the […]
Admin
miCure Therapeutics went through 3 capital raising rounds backed by private investors to progress the development of microRNA based therapy for depression
…
miCure Therapeutics acquired key oligonucleodites patents fron nLife Therapeutics
miCure Therapeutics is a leading-edge biotech company focused on micro-RNA therapeutics and diagnostics for the central nervous system. Current development program based on mir135 mimic as a therapeutic agent for a long term management of Treatment Resistant Depressive patients (TRD patients). Oligonucleotide delivery solutions developed by nLife Therapeutics reinforces this program by reducing the effective […]